treatment
Monica Gandhi MD
treatment
HIV
HIV
08/18/2022
New research indicates that many women living with HIV may prefer a monthly long-acting injectable antiretroviral therapy, once FDA-approved, instead of daily pills. Consultant360 discussed these findings...
08/18/2022
HIV
HIV
06/25/2022
Consultant360 spoke with Keith Horvath, PhD, about his study, which indicated that technology-assisted HIV testing interventions could serve as a key strategy in reaching national and global targets for HIV...
06/25/2022
prevention
prevention
05/20/2022
PrEP has become more mainstream in the media, and the USPSTF recently recommended PrEP for all at-risk populations. Richard Chaisson, MD, shines light on these at-risk populations. 
05/20/2022
medication accesss
medication accesss
05/13/2022
In this Q&A, Monica Gandhi, MD, MPH, discusses interventions to address the health care disparities that exist along the care continuum for certain patient populations who are at-risk for HIV...
05/13/2022
Pre-Exposure Prophylaxis
Pre-Exposure Prophylaxis
01/20/2022
Kathleen Ryan, PhD, answered our questions about her study, which indicated that rapid scale-up of PrEP was possible without the consequence of reduced HIV testing among Australian gay, bisexual, and other...
01/20/2022
prevention
prevention
01/13/2022
Jason J. Ong, PhD, MBBS, from the London School of Hygiene and Tropical Medicine, answers our questions about his team’s research on STI prevalence and incidence among new and persistent users of...
01/13/2022
HIV
HIV
06/18/2018
A new study of more than 27,000 MSM has indicated that increased HIV PrEP use has unexpectedly led to decreased condom use among men not using PrEP. Consultant360 spoke with lead study author Martin Holt,...
06/18/2018